Skip to menu Skip to content Skip to footer

2004

Conference Publication

Perceptions of concordance with medicines: Focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners

Bajramovic Fejzic, J., Emmerton, L. M. and Tett, S. E. (2004). Perceptions of concordance with medicines: Focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. 13th International Social Pharmacy Workshop, Malta, 19-23 July, 2004. Malta: Malta College of Pharmacy Practice.

Perceptions of concordance with medicines: Focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners

2004

Conference Publication

Population pharmacokinetic and pharmacodynamic analysis of leflunomide in rheumatoid arthritis

Chan, V., Charles, B. G. and Tett, S. E. (2004). Population pharmacokinetic and pharmacodynamic analysis of leflunomide in rheumatoid arthritis. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x

Population pharmacokinetic and pharmacodynamic analysis of leflunomide in rheumatoid arthritis

2004

Conference Publication

Working with health professionals and consumers in tandem: What is the evidence?

Tett, S.E (2004). Working with health professionals and consumers in tandem: What is the evidence?. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service.

Working with health professionals and consumers in tandem: What is the evidence?

2004

Conference Publication

Quantifying the use of the 'statin' antilipemic drugs in Nova Scotia, Canada and Queensland, Australia

Nissen, L. M., Cooke, C., Sketris, I. and Tett, S.E. (2004). Quantifying the use of the 'statin' antilipemic drugs in Nova Scotia, Canada and Queensland, Australia. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x

Quantifying the use of the 'statin' antilipemic drugs in Nova Scotia, Canada and Queensland, Australia

2004

Journal Article

Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection

Atcheson, Bronwyn, Taylor, Paul J., Mudge, David W., Johnson, David W., Pillans, Peter I. and Tett, Susan E. (2004). Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection. Journal of Chromatography B, 799 (1), 157-163. doi: 10.1016/j.jchromb.2003.10.033

Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection

2004

Conference Publication

Sample medication: What do Australian general practitioners think?

Nissen, L. M., Hall, K. H. and Tett, S. E. (2004). Sample medication: What do Australian general practitioners think?. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service.

Sample medication: What do Australian general practitioners think?

2004

Conference Publication

An argument for dose individualisation of sirolimus in renal transplant recipients

Dansirikul, C., Duffull, S. B., Morris, R. and Tett, S.E. (2004). An argument for dose individualisation of sirolimus in renal transplant recipients. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.v31_i11_abs.x

An argument for dose individualisation of sirolimus in renal transplant recipients

2004

Journal Article

A perspective on Australia's national medicines policy

Tett, S. E. (2004). A perspective on Australia's national medicines policy. Canadian Journal of Clinical Pharmacology, 11 (1), e28-e38. doi: 10.22374/jptcp.v11i1.62

A perspective on Australia's national medicines policy

2004

Conference Publication

How is leflunomide prescribed and used in Australia? Analysis of prescribing, usage and adverse effect reporting

Chan, V. and Tett, S. E. (2004). How is leflunomide prescribed and used in Australia? Analysis of prescribing, usage and adverse effect reporting. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service.

How is leflunomide prescribed and used in Australia? Analysis of prescribing, usage and adverse effect reporting

2004

Conference Publication

Bayesian population pharmacokinetic analysis of sirolimus

Dansirikul, C., Friberg, L. E., Duffull, S. B., Morris, R. and Tett, S.E. (2004). Bayesian population pharmacokinetic analysis of sirolimus. Population Approach Group in Europe - Thirteenth Meeting (PAGE), Uppsala University, Sweden, 17-18 June 2004. Sweden: Uppsala University.

Bayesian population pharmacokinetic analysis of sirolimus

2004

Journal Article

Rapid determination of the active leflunomide metabolite A77 1726 in human plasma by high-performance liquid chromatography

Chan, V., Charles, B. G. and Tett, S. E. (2004). Rapid determination of the active leflunomide metabolite A77 1726 in human plasma by high-performance liquid chromatography. Journal of Chromatography B-analytical Technologies In The Biomedical And Life Sciences, 803 (2), 331-335. doi: 10.1016/j.jchromb.2004.01.016

Rapid determination of the active leflunomide metabolite A77 1726 in human plasma by high-performance liquid chromatography

2003

Journal Article

Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients

Willis, Charlene, Staatz, Christine E. and Tett, Susan E. (2003). Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients. Therapeutic Drug Monitoring, 25 (2), 158-166. doi: 10.1097/00007691-200304000-00004

Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients

2003

Journal Article

Measurement of free drug and clinical end-point by high-performance liquid chromatography-mass spectrometry: Applications and implications for pharmacokinetic and pharmacodynamic studies

Atcheson, B., Taylor, P. J., Pillans, P. I. and Tett, S. E. (2003). Measurement of free drug and clinical end-point by high-performance liquid chromatography-mass spectrometry: Applications and implications for pharmacokinetic and pharmacodynamic studies. Analytica Chimica Acta, 492 (2003), 157-169. doi: 10.1016/S0003-2670(03)00359-3

Measurement of free drug and clinical end-point by high-performance liquid chromatography-mass spectrometry: Applications and implications for pharmacokinetic and pharmacodynamic studies

2003

Journal Article

Using a problem detection study (PDS) to identify and compare health care provider and consumer views of antihypertensive therapy

Wade, A. H., Weir, D. N., Cameron, A. P. and Tett, S. E. (2003). Using a problem detection study (PDS) to identify and compare health care provider and consumer views of antihypertensive therapy. Journal of Human Hypertension, 17 (17), 397-405. doi: 10.1038/sj.jhh.1001565

Using a problem detection study (PDS) to identify and compare health care provider and consumer views of antihypertensive therapy

2003

Conference Publication

Power calculation for a study with multivariate outcomes

Kirkpatrick, C. M. J., Duffull, S. B. and Tett, S. E. (2003). Power calculation for a study with multivariate outcomes. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., 19-21 Feb. 2003. Sydney:

Power calculation for a study with multivariate outcomes

2003

Conference Publication

Analysis of free mycophenolic acid and its glucuronide in human blood samples

Atcheson, B., Taylor, P. J. and Tett, S. E. (2003). Analysis of free mycophenolic acid and its glucuronide in human blood samples. IATDMCT Congress, Basel, Switzerland, September 2003. New York , U. S.:

Analysis of free mycophenolic acid and its glucuronide in human blood samples

2003

Journal Article

Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil

Shum, B, Duffull, SB, Taylor, PJ and Tett, SE (2003). Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil. British Journal of Clinical Pharmacology, 56 (2003), 188-197. doi: 10.1046/j.1365-2125.2003.01863.x

Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil

2003

Conference Publication

Detecting drug interactions associated with tacrolimus

Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2003). Detecting drug interactions associated with tacrolimus. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., 19-21 Feb. 2003. Sydney:

Detecting drug interactions associated with tacrolimus

2003

Journal Article

Principles and clinical application of assessing alterations in renal elimination pathways

Tett, Susan E., Kirkpatrick, Carl M. J., Gross, Annette S. and McLachlan, Andrew J. (2003). Principles and clinical application of assessing alterations in renal elimination pathways. Clinical Pharmacokinetics, 42 (14), 1193-1211. doi: 10.2165/00003088-200342140-00002

Principles and clinical application of assessing alterations in renal elimination pathways

2003

Journal Article

Doctors perceptions of the influences on their prescribing: a comparison of general practitioners based in rural and urban Australia

Cutts, Christopher and Tett, Susan E. (2003). Doctors perceptions of the influences on their prescribing: a comparison of general practitioners based in rural and urban Australia. European Journal of Clinical Pharmacology, 58 (11), 761-766. doi: 10.1007/s00228-002-0551-5

Doctors perceptions of the influences on their prescribing: a comparison of general practitioners based in rural and urban Australia